Article
|
By Iwan Bertholjotti and Dr. Bernhard Stump,
Lonza
There are three major challenges inherent to commercializing a biotherapeutic: technical challenges, regulatory challenges, and market supply challenges. Working with a partner that can provide a one-stop shop for bioconjugate development and manufacturing can help prevent any missteps that could threaten a biopharmaceutical company’s ability to deliver life-saving drugs to patients who need them.
|